丙硫咪唑15或30mg/(kg·d)治疗蛛网膜下腔和脑室内囊虫病的试验
Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis作者机构：不详 Department of Infectious Disease Instituto Nacional de Neurologa Y Neurociruga Manuel Velasco Suárez Insurgentes Sur 3877 Tlalpan 14269 D.F. Mexico City Mexico
出 版 物：《世界核心医学期刊文摘（神经病学分册）》 (Digest of the World Core Medical Journals:Clinical Neurology)
年 卷 期：2006年第2卷第9期
页 面：9-9页
学科分类：1002[医学-临床医学] 100212[医学-眼科学] 10[医学]
主 题：地塞米松治疗 脑室内囊肿 蛛网膜下腔 丙硫咪唑 囊虫病 试验 皮质激素治疗 常用剂量
摘 要：Thirty-six patients with subarachnoid and intraventricular cysticercosis were randomly assigned to receive albendazole at 15 or 30 mg/kg/day plus dexamethasone for 8 days. Results favored a higher dose, with larger cyst reduction on MRI at 90 and 180 days and higher albendazole sulfoxide levels in plasma. An albendazole course at 30 mg/kg/day combined with corticosteroids is safe and more effective than the usual dose. A single treatment was insufficient in intraventricular and giant cysts.
维普期刊数据库
同方期刊数据库